VIDEO: ‘It’s nice to have another cyclosporine’ for OSD
Click Here to Manage Email Alerts
NASHVILLE, Tenn. — A clinician shared his experience using Vevye in a post-cataract surgery patient with autoimmune disease in this Healio video at Optometry’s Meeting.
Josh Johnston, OD, FAAO, the clinical and residency director at Georgia Eye Partners in Atlanta, said the recently FDA-approved cyclosporine ophthalmic solution 0.1% (Harrow) helped his patient with ocular surface disease that progressed after cataract surgery.
In clinical trials, this water-free, preservative-free, 10 µL drop was associated with an improvement in corneal staining by three levels or more by day 29 in about 66% of patients, he said.
“It’s nice to have another cyclosporine to help decrease ocular surface disease for our patients,” Johnston said.
Collapse
Johnson J, et al. Comanaging surgical complications: What every OD needs to know. Presented at: Optometry’s Meeting; June 19-22, 2024; Nashville, Tenn.
Read more about
Click Here to Manage Email Alerts